Abstract:Background: Inherited medullary thyroid carcinoma (MTC) is primarily caused by RET mutations that are commonly localized in exons 5, 8, 10, 11, and 13-16. In this study, we report pedigrees for individuals with MTC that harbor a germline S409Y variant within exon 6 of the RET proto-oncogene. Methods: Targeted sequencing was used to diagnose four apparently sporadic MTC index cases carrying the germline RET S409Y (c.1226 C>A) variant. Subsequently, 27 relatives of these individuals underwent clinical and genetic assessments and/or thyroid surgery. Furthermore, in silico analyses and in vitro assays were performed to predict or verify the potential oncogenic activity of the S409Y variant. Results: Overall, 15 of 31 participants were found to carry the RET S409Y variant. Of these, 6 presented with isolated MTC (mean age 50.2 years; range 41-75 years), of which 3 presented with neck lymph node metastases and 2 presented with distant liver or lung metastases. Among the remaining 9 carriers, 3 (mean age 56 years; range 41-76 years) had elevated serum calcium-stimulated calcitonin (sCtn) or concurrent marginally elevated serum calcitonin (Ctn) levels, whereas the other 6 (mean age 37.5 years; range 14-52 years) exhibited typical Ctn/sCtn levels (p < 0.05). None of the 15 carriers in these 4 families presented clinical evidence of pheochromocytoma, hyperparathyroidism, or Hirschsprung's disease. In silico analyses revealed that S409Y was a "possibly damaging" mutation that could affect the RET protein inter-domain interface. An in vitro assay revealed that the phosphorylation level of RET tyrosine 905 was relatively higher in the RET S409Y mutant than in wild-type (WT) RET. Moreover, transfection of HEK 293 cells with S409Y enhanced the phosphorylation activity of AKT, ERK pathways, and it increased cell proliferation compared with WT RET, but to a lesser degree than that for the RET C618Y and C634Y mutations. Conclusions: This study demonstrates that the novel germline RET S409Y variant is likely pathogenic and is associated with lower penetrance of MTC than that for the C618Y and C634Y mutations. Individuals with S409Y should be managed using a personalized approach, and additionally, "at-risk" family members should be evaluated. Additional studies are needed to elucidate the correlation between the S409Y mutation and multiple endocrine neoplasia type 2-specific tumors.

Mutations of RET proto-oncogene in Hirschsprung's disease and its allied disorders

Mutation of the RET Proto-Oncogene in Hirschsprung^s Disease

Mutation of RET Gene in Chinese Patients with Hirschsprung’s Disease

[The Mutation Character of the RET Proto-Oncogene in Chinese Patients with Hirschsprung's Disease].

Mutations of RET proto-oncogene in Chinese familial Hirschsprung's disease

Genetic Analysis of RET , EDNRB , and EDN3 Genes and Three SNPs in MCS + 9.7 in Chinese Patients with Isolated Hirschsprung Disease

Sequence Characterization of RET in 117 Chinese Hirschsprung Disease Families Identifies a Large Burden of De Novo and Parental Mosaic Mutations

Relationship Between Polymorphisms and Haplotypes of RET Gene and Hirschsprung's Disease

RET Compound Inheritance in Chinese Patients with Hirschsprung Disease: Lack of Penetrance from Insufficient Gene Dysfunction.

Polymerase Chain Reaction-Single Strand Conformational Polymorphism Analysis of Rearranged During Transfection Proto-Oncogene in Chinese Familial Hirschsprung's Disease.

Analysis of endothelin-B receptor gene in Chinese patients with sporadic Hirschsprung's disease

Non-syndromic Hirschsprung's disease as a result of a RET gene variant

Genetic Variants in RET and Risk of Hirschsprung's Disease in Southeastern Chinese: a Haplotype-Based Analysis

Association Analysis of the RET Proto-Oncogene with Hirschsprung Disease in the Han Chinese Population of Southeastern China

A Single RET Mutation in Hirschsprung Disease Induces Intestinal Aganglionosis Via a Dominant-Negative Mechanism

RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.

Clinical analysis and research in RET proto-oncogene mutation in five MEN2B pedigrees

RET somatic mutations are underrecognized in Hirschsprung disease

Whole genome sequencing reveals epistasis effects within RET for Hirschsprung disease

Whole Exome Sequencing Identifies a Novel Pathogenic RET Variant in Hirschsprung Disease

The Single Nucleotide Polymorphisms in Smad-interacting Protein 1 Gene Contribute to Its Ectopic Expression and Susceptibility in Hirschsprung's Disease.